|
US4444744A
(en)
|
1980-03-03 |
1984-04-24 |
Goldenberg Milton David |
Tumor localization and therapy with labeled antibodies to cell surface antigens
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5374548A
(en)
*
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
|
GB8705477D0
(en)
|
1987-03-09 |
1987-04-15 |
Carlton Med Prod |
Drug delivery systems
|
|
DE3722647A1
(de)
|
1987-07-09 |
1989-01-19 |
Gerhard Ohlenschlaeger |
Galenische verwendung eines tripeptids als arzneimittel
|
|
DE4107154A1
(de)
*
|
1990-10-11 |
1992-04-16 |
Boehringer Mannheim Gmbh |
Monoklonale antikoerper gegen melanom
|
|
AU662311B2
(en)
|
1991-02-05 |
1995-08-31 |
Novartis Ag |
Recombinant antibodies specific for a growth factor receptor
|
|
GB9105292D0
(en)
|
1991-03-13 |
1991-04-24 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
|
US5639641A
(en)
*
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
GB9324807D0
(en)
|
1993-12-03 |
1994-01-19 |
Cancer Res Campaign Tech |
Tumour antibody
|
|
US5622701A
(en)
*
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
US5639863A
(en)
*
|
1994-06-21 |
1997-06-17 |
Dan; Michael D. |
Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
|
|
GB9424449D0
(en)
|
1994-12-02 |
1995-01-18 |
Wellcome Found |
Antibodies
|
|
WO1997002479A2
(en)
|
1995-06-30 |
1997-01-23 |
Yale University |
Human monoclonal anti-tumor antibodies
|
|
GB9601081D0
(en)
|
1995-10-06 |
1996-03-20 |
Cambridge Antibody Tech |
Specific binding members for human transforming growth factor beta;materials and methods
|
|
JP2001504326A
(ja)
|
1996-10-18 |
2001-04-03 |
ジェネンテック インコーポレーテッド |
抗ＥｒｂＢ２抗体
|
|
ES2293682T5
(es)
*
|
1997-05-15 |
2011-11-17 |
Genentech, Inc. |
Anticuerpo anti-apo2.
|
|
US6185924B1
(en)
|
1997-10-17 |
2001-02-13 |
Hitachi, Ltd. |
Gas turbine with turbine blade cooling
|
|
EP0927757A1
(en)
|
1997-12-03 |
1999-07-07 |
Leadd B.V. |
Methods and means for inducing apoptosis by interfering with Bip-like proteins
|
|
EP1068312A2
(en)
*
|
1998-04-09 |
2001-01-17 |
Genset |
5' ests and encoded human proteins
|
|
US6846637B1
(en)
|
1998-06-18 |
2005-01-25 |
Imed Ab |
Fas peptides and antibodies for modulating apoptosis
|
|
AU766551C
(en)
*
|
1998-08-28 |
2005-02-17 |
Genentech Inc. |
Human anti-factor IX/IXa antibodies
|
|
GB9822115D0
(en)
*
|
1998-10-09 |
1998-12-02 |
King S College London |
Treatment of inflammatory disease
|
|
PT1141019E
(pt)
|
1998-12-22 |
2004-09-30 |
Heinz Peter Vollmers |
Fragmento da glicoproteina cd55/daf para a obtencao de medicamentos antitumorais com elevada eficacia assim como processo para a sua utilizacao
|
|
AU3921600A
(en)
|
1999-03-25 |
2000-10-09 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human il-12 and methods for producing
|
|
US7049132B1
(en)
*
|
1999-06-28 |
2006-05-23 |
University Of Southern California |
Stress-responsive induction of a therapeutic agent and methods of use
|
|
EP1212422B1
(en)
*
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
|
US6677442B1
(en)
*
|
1999-10-29 |
2004-01-13 |
University Of Kentucky Research Foundation |
Nucleic acid encoding human REV1 protein
|
|
WO2001062932A1
(en)
|
2000-02-23 |
2001-08-30 |
Amgen Inc. |
Antagonistic selective binding agents of osteoprotegerin binding protein
|
|
TWI318983B
(en)
|
2000-05-02 |
2010-01-01 |
Uab Research Foundation |
An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
|
|
US7220840B2
(en)
*
|
2000-06-16 |
2007-05-22 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator protein
|
|
EP2275449B1
(en)
|
2000-06-16 |
2016-09-28 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to BLyS
|
|
UA81743C2
(uk)
*
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
|
CA2426710A1
(en)
*
|
2000-11-08 |
2002-10-10 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
|
US20030105003A1
(en)
*
|
2001-04-05 |
2003-06-05 |
Jan Nilsson |
Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
|
|
CA2443862A1
(en)
*
|
2001-04-17 |
2002-10-24 |
Peizhi Luo |
Structure-based construction of human antibody library
|
|
AU2002325164B2
(en)
|
2001-07-24 |
2008-12-04 |
Debiovision Inc. |
Receptor, the use thereof, and mouse antibodies
|
|
US7671010B2
(en)
*
|
2002-08-30 |
2010-03-02 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US20040048243A1
(en)
*
|
2001-09-07 |
2004-03-11 |
Wadih Arap |
Methods and compositions for in vitro targeting
|
|
ES2384100T3
(es)
|
2001-12-03 |
2012-06-29 |
Alexion Pharmaceuticals, Inc. |
Método para producir anticuerpos híbridos
|
|
DE10210427A1
(de)
*
|
2002-03-09 |
2003-10-09 |
Hans Konrad Mueller-Hermelink |
Humaner monoklonaler Antikörper
|
|
EP1572079A4
(en)
|
2002-03-29 |
2006-09-06 |
Centocor Inc |
MAMMAL-CDR MIMETIC BODIES, COMPOSITIONS, PROCESSES AND APPLICATION PURPOSES
|
|
DK1517921T3
(da)
*
|
2002-06-28 |
2006-10-09 |
Domantis Ltd |
Immunglobulin-enkeltvariable antigen-bindende domæner og dobbeltspecifikke konstruktioner deraf
|
|
CA2491669A1
(en)
|
2002-07-04 |
2004-01-15 |
Oncomab Gmbh |
Neoplasm specific antibodies and uses thereof
|
|
DE10230516A1
(de)
|
2002-07-06 |
2004-01-15 |
Müller-Hermelink, Hans Konrad, Prof. Dr. |
Humaner monoklonaler Antikörper
|
|
AU2002364501A1
(en)
|
2002-08-30 |
2004-03-19 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
SE0302312D0
(sv)
*
|
2002-10-04 |
2003-08-27 |
Forskarpatent I Syd Ab |
Peptide-based passive immunization therapy for treatment of atherosclerosis
|
|
DE10311248A1
(de)
|
2003-03-14 |
2004-09-30 |
Müller-Hermelink, Hans Konrad, Prof. Dr. |
Humaner monoklonaler Antikörper
|
|
WO2005001052A2
(en)
|
2003-06-06 |
2005-01-06 |
University Of Massachusetts |
Modulation of apoptosis
|
|
JP2007509616A
(ja)
|
2003-10-27 |
2007-04-19 |
ユニバーシティ オブ サウザーン カリフォルニア |
アポトーシスを調節する方法および組成物
|
|
CA2545512A1
(en)
|
2003-11-12 |
2005-10-13 |
Oncomab Gmbh |
Methods of identifying neoplasm-specific antibodies and uses thereof
|
|
DE10353175A1
(de)
|
2003-11-14 |
2005-06-16 |
Müller-Hermelink, Hans Konrad, Prof. Dr. |
Humaner monoklonaler Antikörper mit fettsenkender Wirkung
|
|
EP1531162A1
(en)
|
2003-11-14 |
2005-05-18 |
Heinz Vollmers |
Adenocarcinoma specific antibody SAM-6, and uses thereof
|
|
WO2005065418A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy
|
|
GB0404936D0
(en)
|
2004-03-04 |
2004-04-07 |
Univ London |
Screen
|
|
DE102004015179A1
(de)
|
2004-03-25 |
2005-10-13 |
Oncomab Gmbh |
Antigen des PM-2 Antikörpers und dessen Verwendung
|
|
CA2683287A1
(en)
*
|
2006-11-27 |
2008-12-18 |
Patrys Limited |
Novel glycosylated peptide target in neoplastic cells
|
|
US20110207917A1
(en)
|
2009-02-09 |
2011-08-25 |
Patrys Limited |
Sam-6 variants, target and methods of use
|